Immunotherapy with autologous dendritic cells and tumor-specific synthetic peptides for synovial sarcoma

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 3, 2002, Pages 220-223

  Matsuzaki, Akinobu ^a   Suminoe, Aiko ^a   Hattori, Hiroyoshi ^a   Hoshina, Takayuki ^a   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cytotoxic T lymphocytes; Dendritic cell; Immunotherapy; Synovial sarcoma; Synthetic peptide

Indexed keywords

CARBOPLATIN; COLONY STIMULATING FACTOR 1; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 4; PIRARUBICIN; SYNTHETIC PEPTIDE; THIOTEPA;

ARTICLE; CANCER IMMUNOTHERAPY; CASE REPORT; CHROMOSOME 18; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; FEMALE; HUMAN; LUNG METASTASIS; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; STEM CELL TRANSPLANTATION; SYNOVIAL SARCOMA; X CHROMOSOME;

ANTIGENS, NEOPLASM; BONE NEOPLASMS; CELLS, CULTURED; CHILD; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DNA PRIMERS; FEMALE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-4; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; ONCOGENE PROTEINS, FUSION; PEPTIDES; RADIOGRAPHY, THORACIC; SARCOMA, SYNOVIAL; T-LYMPHOCYTES, CYTOTOXIC; THORACIC NEOPLASMS;

EID: 0036214287     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200203000-00012     Document Type: Article

References (18)

1. Vaccination against human cancers
2. Dendritic cells and the control of immunity
3. Efficient presentation of soluble antigen by cultured dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
4. Cancer antigen. Identification of human tumor antigens by serological expression cloning
5. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
6. Immunologic and therapeutic evaluation of a synthetic peptide for the treatment of patients with metastatic melanoma
7. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
8. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrid
9. Other soft tissue sarcoma of childhood
10. Detection of SYT-SSX1/2 fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma
11. Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization
12. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus
13. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma
14. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome
15. SYT-SSX gene fusion as a determinant of morphology and progression in synovial sarcoma
16. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines
17. Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia
18. Dendritic cells directly trigger NL cell functions: Cross-talk relevant in innate anti-tumor immune response in vitro